Drug profile · INN
follitropin alfa
BEMFOLA
follitropin alfa (BEMFOLA) is a follicle stimulating hormone receptor agonist. Associated with Merck KGaA, Darmstadt, Germany.
EMA: approved TGA: approved Genito-urinary system and sex hormones (G03) G03GA05
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — follitropin alfa
- Class
- Genito-urinary system and sex hormones (G03)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.83
Quick answer
follitropin alfa (BEMFOLA) is a follicle stimulating hormone receptor agonist. Associated with Merck KGaA, Darmstadt, Germany.
Key facts
INN follitropin alfa
Brand BEMFOLA
Mechanism Follicle stimulating hormone receptor agonist
Target Follicle-stimulating hormone receptor
Therapeutic class Genito-urinary system and sex hormones (G03)
ATC code G03GA05
Originator Merck KGaA, Darmstadt, Germany
Mechanism of action
Follicle stimulating hormone receptor agonist
Primary target: Follicle-stimulating hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is follitropin alfa?
follitropin alfa (BEMFOLA) is a follicle stimulating hormone receptor agonist. Associated with Merck KGaA, Darmstadt, Germany.
What is the brand name for follitropin alfa?
BEMFOLA is a marketed brand name for follitropin alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.